EPISODE · Oct 20, 2021 · 38 MIN
Dr Paul Jourdan: "Lots of people love to knock Aim. I'm absolutely not in that camp"
from Investors' Chronicle
Paul Jourdan, CEO of Amati Global Investors, tells Christopher Akers why he thinks the Alternative Investment Market is an asset of national importance and shares his thoughts on overpricing in "the year of IPOs". He explains Amati's approach to ESG and discusses the stocks that have been important for them over the last year.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
Ready to play
Dr Paul Jourdan: "Lots of people love to knock Aim. I'm absolutely not in that camp"
No transcript for this episode yet
Similar Episodes
No similar episodes found.